The world of ophthalmology faces a promising yet complex challenge as it navigates the treatment of age-related macular degeneration (AMD), a leading cause of vision loss across the globe. In recent years, advancements in medical research have unveiled new pathways to tackle this degenerative
A recent study conducted by the Cleveland Clinic sheds light on the real-world challenges faced by injectable medications used for obesity treatment, namely semaglutide and tirzepatide. These medications, approved by the FDA for both obesity management and type 2 diabetes care, are marketed under
In the rapidly evolving landscape of cancer treatments, Aumseqa (aumolertinib) has emerged as a promising advancement against non-small cell lung cancer (NSCLC) characterized by EGFR mutations. Recently approved by the Medicines and Healthcare products Regulatory Agency (MHRA), Aumseqa is
The field of regenerative medicine has witnessed a groundbreaking development as an innovative clinical trial gets underway at Princess Alexandra Hospital. This trial focuses on the reconstruction of jawbones using advanced 3D-printed implants—marking a significant leap forward for both
With a background steeped in biopharmaceutical innovation, Ivan Kairatov is a leading expert in oncology therapeutics. His insights into the development and approval of new cancer treatments are invaluable, especially regarding the European Commission's recent decision on AstraZeneca's Calquence
Childhood cancer continues to be a daunting global health challenge, affecting around 400,000 children annually. Early diagnosis remains a cornerstone for improving the survival rate and quality of life for these young patients. In 2018, the World Health Organization (WHO) launched the Global
